CHRISTINE GARRITY: Open Payments
NPI 1821590878 · CALIFORNIA, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$389 in 29 payments from 7 companies in 2025. Trend: 2023 $363 · 2024 $410 · 2025 $389
Food & beverage: $389
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $205 |
| Lilly USA, LLC | 3 | $58 |
| Novo Nordisk Inc | 2 | $51 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| Dynavax Technologies Corporation | 1 | $15 |
Products named: QULIPTA, UBRELVY, MOUNJARO, VRAYLAR, Rybelsus, JOURNAVX, SHINGRIX, FARXIGA.
Industry payments across MD — which companies pay providers there.
